Armistice Capital »

Cormedix Inc cormedix shares owned by Armistice Capital

Quarter-by-quarter ownership of Cormedix Inc cormedix (CRMD) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Cormedix Inc cormedix

Tip: Access up to 7 years of quarterly data

All positions including Cormedix Inc cormedix held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cormedix Inc cormedix by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9M 500k 7.85

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Cormedix Inc cormedix

BlackRock
Deep Track Capital
Vanguard Capital Management
State Street Corporation
Royce & Associates
Geode Capital Management
UBS Group
Susquehanna International
Oberweis Asset Management
Alyeska Investment Group
Marshall Wace
Northern Trust
Vanguard Portfolio Management
Pacer Advisors
Hrt Financial

View all funds holding Cormedix Inc cormedix